Sellas Life Sciences faces high risk in the Phase 3 REGAL AML trial for GPS. Click here to know why I rate the SLS stock a ...

Large Norwegian registry data links birth size and maternal diabetes with higher multiple sclerosis risk, suggesting prenatal ...

Danish biotechnology company Genmab has announced top line results from the Phase III EPCORE DLBCL-1 trial, highlighting improved progression-free survival (PFS) for its subcutaneous bispecific ...

Yoga appears to help accelerate opioid withdrawal recovery when paired with buprenorphine treatment, based on a recent study.

Intake of preservatives is associated with increased cancer incidence, according to a recent study from France.

Incyte (Nasdaq: INCY) on Thursday unveiled breakthrough results from a pivotal late-stage cancer trial that could redefine first-line treatment for one of the most aggressive forms of ...

(HealthDay News) — For patients with primary solid tumors receiving cancer therapy, clonal hematopoiesis of indeterminate potential (CHIP) is associated with an increased risk for cardiovascular ...

Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor degrader (SERD) to a 30% reduction in the risk of invasive disease ...

In patients with obesity and heart failure with preserved ejection fraction (HFpEF), weekly treatment with tirzepatide over approximately two years reduced the risk of worsening heart failure events, ...

The First Phase III Study Testing Ivonescimab Now Represents the First Statistically Significant OS Benefit Achieved by an Ivonescimab-Containing Regimen Ivonescimab Plus Chemotherapy Demonstrates ...

Former Chelsea winger Eden Hazard has sent a heart-warming message to fans after being inducted into the Premier League Hall of Fame on Wednesday. It was going to happen sooner or later, but Hazard ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis-free survival than leuprolide alone among patients with biochemically ...